Clinical Trial Details
| Trial ID: | L0085 |
| Source ID: | NCT04952506 |
| Associated Drug: | Ckd-349 F1 Tab. |
| Title: | Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Chronic Renal Failure |
| Interventions: | DRUG: CKD-349 F1 Tab.|DRUG: CKD-349 F2 Tab.|DRUG: D113 Tab. |
| Outcome Measures: | Primary: AUCt of CKD-349, D113, Area under the CKD-349/D113 concentration in blood-time curve from zero to final, Pre-dose (0 hour), post-dose 0.17, 0.33, 0.5, 0.75, 1, 1.33, 1.67, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12, 24, 48 hours|Cmax of CKD-349, D113, The maximum CKD-349/D113 concentration in blood sampling time t, Pre-dose (0 hour), post-dose 0.17, 0.33, 0.5, 0.75, 1, 1.33, 1.67, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12, 24, 48 hours | |
| Sponsor/Collaborators: | Sponsor: Chong Kun Dang Pharmaceutical |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 25 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2021-07-19 |
| Completion Date: | 2021-08-20 |
| Results First Posted: | |
| Last Update Posted: | 2024-01-24 |
| Locations: | Chungnam National University Hospital, Daejeon, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT04952506 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|